Omar Makram Elsayed, MD MPH (Omar M Makram)
@OelsayedMD
Followers
1K
Following
1K
Media
15
Statuses
241
PGY3 IM Research Resident @MCG_InternalMed | MPH @LSHTM 🇬🇧 | MSc @gtomsanalytics 🐝 I Postdoc @MethodistHosp 🇺🇸 | MD 🇪🇬 |#Epidemiology #DataScience
Augusta, GA
Joined March 2022
🕵️♂️Different stages of CKMS require different approaches! ⏰ Transition from stage to stage varies with concurrent risk factors and cancer treatment! ‼️Social Determinants of Health play a key role in management! @virajshahr @DocHariKris @OelsayedMD
0
3
4
New Review! 🚨 Cardio-Kidney-Metabolic Syndrome is a spectrum of inflammatory states 🔥, marked by dysfunction across cardiovascular, renal, and metabolic systems. What are the implications of CKMS in patients with cancer? 💡 #CancerResearch @avirupguha
https://t.co/577yblAqNn
link.springer.com
Current Atherosclerosis Reports - This review aims to examine the clinical relevance of cardio-kidney-metabolic syndrome (CKMS) in oncology, highlighting its role as both a preexisting comorbidity...
1
6
11
Feeling grateful and proud today. Thanks to the exceptional collaborative efforts and the mentoring of Dr. @avirupguha, we are able to share our projects with millions. See you all soon! #AHA25 @AHAScience
Congratulations to the @WellstarHealth and @MCG_AUG Cardiology teams for having nine abstracts accepted to #AHA25 @AHAScience sessions, covering topics such as population health, AI, breast cancer treatments, obesity, and trial inequities. Special thanks to @AUG_University
2
1
9
Congratulations to the @WellstarHealth and @MCG_AUG Cardiology teams for having nine abstracts accepted to #AHA25 @AHAScience sessions, covering topics such as population health, AI, breast cancer treatments, obesity, and trial inequities. Special thanks to @AUG_University
3
7
16
Hello #MedTwitter #MedX 👋 I’m Khaled Taghlabi, #IMG from 🇱🇧 & Clinical Research Fellow @MethodistHosp applying to #Neurosurgery for #Match2026 From resuscitating TBI patients in an 🚑 to co-founding @clininnovlab & spearheading global collaborations, my journey forged
10
19
239
🚀 AI in Cardio-Oncology: A New Era Large language models (LLMs) like GPT-4 can streamline cardio-oncology workflows—clinical note summarization, EHR data extraction, & trial matching—while maintaining accuracy & speed. 🔗 DOI: 10.1016/j.jacadv.2025.102117 (new pub by superstars
3
12
33
Check out the great work by our lab rising stars 🌟🎉
🚀 AI in Cardio-Oncology: A New Era Large language models (LLMs) like GPT-4 can streamline cardio-oncology workflows—clinical note summarization, EHR data extraction, & trial matching—while maintaining accuracy & speed. 🔗 DOI: 10.1016/j.jacadv.2025.102117 (new pub by superstars
0
2
10
🎧 حلقة جديدة من ABCDE Podcast 🎙️ واللي بنبدأ بيها سلسلة جديدة عن Physician-Scientist Pathways in the U.S. ضيفنا النهاردة هو د. عمر مكرم السيد – أحد الأطباء المصريين اللي قدروا يجمعوا بين التميز في الشغل الإكلينيكي والبحث العلمي 👨⚕️🔬 Dr. Omar is currently a resident on the
4
14
71
Here’s to my first review as a Cardio-Oncology researcher! Dive into our latest publication in Current Cardiology Reports on how AI is rapidly transforming the current state of Cardio-Oncology, with breakthroughs like AI-ECG 📈, Multimodal AI Imaging 🫀📸, and AI-Integrated
🚨 New Review Alert! 🚨 AI is revolutionizing Cardio-Oncology by enhancing early detection, risk stratification, and personalized care for cancer patients at risk of CV disease. Can AI be the key to better outcomes? 🧵👇 🔗 https://t.co/cUht3ROkXF
@OncoAlert /3
1
2
5
🔍 AI applications in cardio-oncology: ✅ AI-ECG models for early cardiotoxicity detection 📉 ✅ Imaging & multi-omics for personalized risk stratification 🧬 ✅ Real-time monitoring via wearable tech ⌚ Challenges? Data heterogeneity, bias & regulatory hurdles remain. @virajshah
1
4
10
💡 The future of AI in cardio-oncology? 🔹 Explainable AI for clinician trust 🔹 AI-driven drug discovery 🔹 Integrating AI into clinical workflows for real-time decision-making 📢 Time to bring AI to the bedside! Thoughts? 🤔 #CardioOnc #AIHealth 3/3 @drbrowncares
0
4
10
‼️🔔 Big news! Our latest review, led by the incredible @virajshahr 🌟 with the invaluable mentorship of @avirupguha , is now out! Grateful for the mentorship and vision. Check it out! #CardioOncology #AI @MCG_InternalMed @MCG_AUG
🚨 New Review Alert! 🚨 AI is revolutionizing Cardio-Oncology by enhancing early detection, risk stratification, and personalized care for cancer patients at risk of CV disease. Can AI be the key to better outcomes? 🧵👇 🔗 https://t.co/cUht3ROkXF
@OncoAlert /3
0
3
11
🫀🎗️ It was a great opportunity to present alongside @cezar_ciliescu at @4TSConference. Honored to be part of the first-ever dedicated cardio-oncology session for an interventional cardiology audience!! @anita_deswal @docHJ #CardioOnc #cardiotwitter
1
5
30
Happy Valentine’s Day with this great review article from our cardio-oncology partners: Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk Factors. Cardiol Clin. 2025 Feb;43(1):1-11. @avirupguha
https://t.co/7GrqZqF8zD
0
1
5
Thank you for highlighting our work and impressive results from @NCICCR_UroOnc @NCICancerStats #SEERMedicare with excellent work by @TarekNahle and @OelsayedMD to be presented at #GU25 @GACancerCenter @MCGCardFellows @MCG_AUG @NCIJBSloan
0
2
10
Ab#315 @ASCO #GU25 by @TarekNahle @avirupguha 👉 https://t.co/OvC9wLrxab 👉In SEER-Medicare database in pts w/ #prostatecancer 👉Low socioeconomic position associated w/⬆️risk of CV mortality, PCa specific-mortality & all-cause mortality👇@OncoAlert @urotoday @PCF_Science
0
14
28
Cancer specific cardiovascular risk score is now available for use through this research group comprising some of @ICOSociety members including Dr @avirupguha and @sdent_cardioonc. Great work to improve cardiovascular health of lung, colon and breast cancer survivors!
Got interested and want to give these cancer-specific CVD risk estimators a try? We've made it easy for you! Breast Cancer: https://t.co/LEkW6BTGfn Colorectal Cancer: https://t.co/1xvrQzEDdL Lung Cancer: https://t.co/tK4XjBhR88
0
14
31
Got interested and want to give these cancer-specific CVD risk estimators a try? We've made it easy for you! Breast Cancer: https://t.co/LEkW6BTGfn Colorectal Cancer: https://t.co/1xvrQzEDdL Lung Cancer: https://t.co/tK4XjBhR88
CVD risk is up to 3x higher in cancer patients, but traditional risk scores fail to account for cancer-specific factors. @nickolastab helped us developed ML-driven, cancer-specific CVD risk scores that outperform conventional models. #CardioOnc #CancerCare #cardiosky
0
8
17
Grateful to work with an incredible team on such an important study! ML-driven #cancer-specific #CVD risk score could really outperform traditional models—addressing a critical gap in cardio-oncology. Excited to see its impact! #CardioOnc #CancerCare #MachineLearning
CVD risk is up to 3x higher in cancer patients, but traditional risk scores fail to account for cancer-specific factors. @nickolastab helped us developed ML-driven, cancer-specific CVD risk scores that outperform conventional models. #CardioOnc #CancerCare #cardiosky
0
1
6
CVD risk is up to 3x higher in cancer patients, but traditional risk scores fail to account for cancer-specific factors. @nickolastab helped us developed ML-driven, cancer-specific CVD risk scores that outperform conventional models. #CardioOnc #CancerCare #cardiosky
3
21
48